Alembic Pharmaceuticals Limited announces completion of USFDA Inspection at Aleor Dermaceuticals Limited

Alembic Pharmaceuticals LimitedAleor Dermaceuticals Ltd. (Aleor), a 60:40 Joint Venture between Alembic Pharmaceuticals Ltd. (Alembic) and Orbicular Pharmaceutical Technologies Pvt. Ltd. (Orbicular), has completed United States Food and Drug Administration (USFDA) inspection at its formulation manufacturing facility located at Karakhadi, Gujarat, India; with two observations. The inspection was carried out from 4th February, 2019 to Sth February, 2019.

avatar
  Subscribe  
Notify of